Document:

<PAGE>

                                                                   EXHIBIT 10.3

THIS WARRANT AND ANY SECURITIES ACQUIRED UPON THE EXERCISE OF THIS WARRANT HAVE
NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY
APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, OR OTHERWISE
TRANSFERRED, PLEDGED, OR HYPOTHECATED UNLESS AND UNTIL SUCH SECURITIES ARE
REGISTERED UNDER SUCH ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION,
SATISFACTORY TO THE COMPANY, OF COUNSEL IS OBTAINED TO THE EFFECT THAT SUCH
REGISTRATION IS NOT REQUIRED.

              VOID AFTER 5:00 P.M. EASTERN TIME, DECEMBER 31, 2005

                                    WARRANT

                              FOR THE PURCHASE OF

                         50,000 SHARES OF COMMON STOCK

                                       OF

                         HORIZON MEDICAL PRODUCTS, INC.

1.       Warrant.

         THIS CERTIFIES THAT, in consideration of $10.00 and other good and
valuable consideration, duly paid by or on behalf of Lippert/Heilshorn &
Associates, Inc. ("Holder"), as registered owner of this Warrant, to Horizon
Medical Products, Inc. ("Company"), Holder is entitled, at any time or from
time to time on or after December 31, 2002 ("Commencement Date"), and at or
before 5:00 p.m., Eastern Time December 31, 2005 ("Expiration Date"), but not
thereafter, to subscribe for, purchase and receive, in whole or in part, up to
fifty thousand (50,000) shares of Common Stock of the Company, $0.001 par value
("Common Stock"). If the Expiration Date is a day on which banking institutions
are authorized by law to close, then this Warrant may be exercised on the next
succeeding day which is not such a day in accordance with the terms herein.
During the period ending on the Expiration Date, the Company agrees not to take
any action that would terminate the Warrant. This Warrant is initially
exercisable at ninety-three cents ($0.93) per share of Common Stock purchased;
provided, however, that upon the occurrence of any of the events specified in
Section 5 hereof, the rights granted by this Warrant, including the exercise
price and the number of shares of Common Stock to be received upon such
exercise, shall be adjusted as therein specified. The term "Exercise Price"
shall mean the initial exercise price or the adjusted exercise price, depending
on the context, of a share of Common Stock. The term "Securities" shall mean
the shares of Common Stock issuable upon exercise of this Warrant.

2.       Exercise.

         2.1      Exercise Form. In order to exercise this Warrant, the
exercise form attached hereto must be duly executed and completed and delivered
to the Company, together with this Warrant and payment of the Exercise Price
for the Securities being purchased. If the subscription rights represented
hereby shall not be exercised at or before 5:00 p.m., Eastern time, on the
Expiration Date, this Warrant shall become and be void without further force or
effect, and all rights represented hereby shall cease and expire.

<PAGE>

         2.2      Legend. Each certificate for Securities purchased under this
Warrant shall bear a legend as follows, unless such Securities have been
registered under the Securities Act of 1933, as amended ("Act"):

                  THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN
                  REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED OR
                  ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE OFFERED,
                  SOLD, OR OTHERWISE TRANSFERRED, PLEDGED, OR HYPOTHECATED
                  UNLESS AND UNTIL SUCH SECURITIES ARE REGISTERED UNDER SUCH
                  ACT AND APPLICABLE STATE SECURITIES LAWS OR AN OPINION,
                  SATISFACTORY TO THE COMPANY, OF COUNSEL IS OBTAINED TO THE
                  EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.

         2.3      Conversion Right.

                  2.3.1    Determination of Amount. In lieu of the payment of
the Exercise Price in cash, the Holder shall have the right (but not the
obligation) to convert this Warrant, in whole or in part, into Common Stock
("Conversion Right"), as follows: upon exercise of the Conversion Right, the
Company shall deliver to the Holder (without payment by the Holder of any of the
Exercise Price) that number of shares of Common Stock equal to the quotient
obtained by dividing (x) the "Value" (as defined below) of the portion of the
Warrant being converted at the time the Conversion Right is exercised by (y) the
Market Price on the date of conversion. The "Value" of the portion of the
Warrant being converted shall equal the remainder derived from subtracting (a)
the Exercise Price multiplied by the number of shares of Common Stock being
converted from (b) the Market Price of the Common Stock on the date of
conversion multiplied by the number of shares of Common Stock being converted.
As used herein, the term "Market Price" at any date shall be deemed to be the
last reported sale price of the Common Stock on such date, or, in case no such
reported sale takes place on such day, the average of the last reported sales
prices for the immediately preceding three trading days, in either case as
officially reported by the principal securities exchange on which the Common
Stock is listed or admitted to trading, or, if the Common Stock is not listed or
admitted to trading on any national securities exchange or if any such exchange
on which the Common Stock is listed is not its principal trading market, the
last reported sale price as furnished by the National Association of Securities
Dealers, Inc. ("NASD") through the NASDAQ National Market or SmallCap Market,
or, if applicable, the OTC Bulletin Board, or if the Common Stock is not listed
or admitted to trading on any of the foregoing markets, or similar organization,
as determined in good faith by resolution of the Board of Directors of the
Company, based on the best information available to it.

                  2.3.2    Exercise of Conversion Right. The Conversion Right
may be exercised by the Holder on any business day on or after the Commencement
Date and not later than the Expiration Date by delivering the Warrant with a
duly executed exercise form attached hereto with the conversion section
completed to the Company, exercising the Conversion Right and specifying the
total number of shares of Common Stock the Holder will purchase pursuant to such
conversion.

3.       Transfer.

         3.1      Transferability. Subject to the provisions of this Section 3,
this Warrant and all rights hereunder are transferable, in whole or in part,
upon surrender of this Warrant with a properly executed

                                      -2-
<PAGE>

assignment (in the form attached hereto) at the principal office of the
Company, but only after the Company's prior written consent to such transfer.

         3.2      Representations of Holder. By accepting this Warrant, the
Holder represents and warrants to the Company as follows:

                  (a)      The Warrant and the Securities issuable upon
exercise of this Warrant will be acquired for investment for the Holder's own
account and not with a view to the sale or distribution of any part thereof,
and the Holder has no present intention of selling or engaging in any public
distribution of the same except pursuant to a registration or exemption from
the Securities Act of 1933, as amended ("Securities Act").

                  (b)      The Holder understands and acknowledges (i) that the
Securities issuable upon exercise of the Holder's rights contained herein are
not registered under the Securities Act or qualified under applicable state
securities laws because the issuance contemplated by this Warrant will be
exempt from the registration and qualification requirements thereof, and (ii)
that the Company's reliance on such exemption is predicated on the accuracy of
the representations set forth in this Section 3.2.

                  (c)      The Holder has such knowledge and experience in
financial and business matters as to be capable of evaluating the merits and
risks of its investment and has the ability to bear the economic risks of its
investment.

                  (d)      The Holder understands that if the Company's Common
Stock ceases to be registered with the Securities and Exchange Commission
pursuant to paragraph 12 of the Securities Exchange Act of 1934 (the "Exchange
Act"), or if the Company ceases to file the reports required under the Exchange
Act, or if a registration statement covering the securities under the
Securities Act is not in effect when it desires to resell (i) this Warrant or
(ii) the Securities issuable upon exercise of this Warrant, it may be required
to hold such securities for an indefinite period. The Holder is aware of the
provisions of Rule 144 promulgated under the Securities Act.

                  (e)      The Holder will not offer, sell, or otherwise
dispose of this Warrant or any Securities to be issued upon exercise hereof
except under circumstances that will not result in a violation of the
Securities Act or any state securities laws.

                  (f)      Upon exercise of this Warrant, the Holder shall, if
requested by the Company, confirm in writing, in a form satisfactory to the
Company, that the Warrant shares so purchased are being acquired solely for the
Holder's own account and not as a nominee for any other party, for investment,
and not with a view toward distribution or resale.

         3.3      Securities Law Matters. This Warrant and the Securities may
not be sold or transferred unless either (i) they first shall have been
registered under the Securities Act, or (ii) if requested by the Company, the
Company first shall have been furnished with an opinion of legal counsel,
reasonably satisfactory to the Company, to the effect that such sale or
transfer is exempt from the registration requirements of the Act.
Notwithstanding the foregoing, no registration or opinion of counsel shall be
required for a sale or transfer made in accordance with Rule 144 under the Act
provided that the Company shall have been furnished with such information as
the Company may reasonably request to provide reasonable assurance that the
requirements of Rule 144 have been satisfied.

                                      -3-
<PAGE>

4.       New Warrants to be Issued.

         4.1      Partial Exercise or Transfer. Subject to the restrictions in
Section 3 hereof, this Warrant may be exercised or assigned in whole or in
part. In the event of the exercise or assignment hereof in part only, upon
surrender of this Warrant for cancellation, together with the duly executed
exercise or assignment form and funds (or conversion equivalent) sufficient to
pay any Exercise Price and/or transfer tax, the Company shall cause to be
delivered to the Holder without charge a new Warrant of like tenor to this
Warrant in the name of the Holder evidencing the right of the Holder to
purchase the aggregate number of shares of Common Stock and Warrants
purchasable hereunder as to which this Warrant has not been exercised or
assigned.

         4.2      Lost Certificate. Upon receipt by the Company of evidence
satisfactory to it of the loss, theft, destruction, or mutilation of this
Warrant and of reasonably satisfactory indemnification, the Company shall
execute and deliver a new Warrant of like tenor and date. Any such new Warrant
executed and delivered as a result of such loss, theft, mutilation, or
destruction shall constitute a substitute contractual obligation on the part of
the Company.

5.       Adjustments.

         5.1      Adjustments to Exercise Price and Number of Securities. The
Exercise Price and the number of shares of Common Stock underlying this Warrant
shall be subject to adjustment from time to time as hereinafter set forth:

                  5.1.1    Stock Dividends - Recapitalization,
Reclassification, Split-Ups. If, after the date hereof, and subject to the
provisions of Section 5.2 below, the number of outstanding shares of Common
Stock is increased by a stock dividend on the Common Stock payable in shares of
Common Stock or by a split-up, recapitalization, or reclassification of shares
of Common Stock or other similar event, then, on the effective date thereof,
the number of shares of Common Stock issuable on exercise of this Warrant shall
be increased in proportion to such increase in outstanding shares.

                  5.1.2    Aggregation of Shares. If after the date hereof, and
subject to the provisions of Section 5.2, the number of outstanding shares of
Common Stock is decreased by a consolidation, combination, or reclassification
of shares of Common Stock or other similar event, then, upon the effective date
thereof, the number of shares of Common Stock issuable on exercise of this
Warrant shall be decreased in proportion to such decrease in outstanding
shares.

                  5.1.3    Adjustments in Exercise Price. Whenever the number
of shares of Common Stock purchasable upon the exercise of this Warrant is
adjusted, as provided in this Section 5.1, the Exercise Price shall be adjusted
(to the nearest cent) by multiplying such Exercise Price immediately prior to
such adjustment by a fraction (x), the numerator of which shall be the number
of shares of Common Stock purchasable upon the exercise of this Warrant
immediately prior to such adjustment, and (y) the denominator of which shall be
the number of shares of Common Stock so purchasable immediately thereafter.

                  5.1.4    Replacement of Securities Upon Reorganization, etc.
In case of any reclassification or reorganization of the outstanding shares of
Common Stock other than a change covered by Section 5.1.1 hereof or which
solely affects the par value of such shares of Common Stock, or in the case of
any merger or consolidation of the Company with or into another corporation
(other than a consolidation or merger in which the Company is the continuing
corporation and which does not result in any reclassification or reorganization

                                      -4-
<PAGE>

of the outstanding shares of Common Stock), or in the case of any sale or
conveyance to another corporation or entity of the property of the Company as
an entirely or substantially as an entirety in connection with which the
Company is dissolved, the Holder of this Warrant shall have the right
thereafter (until the expiration of the right of exercise of this Warrant) to
receive upon the exercise hereof, for the same aggregate Exercise Price payable
hereunder immediately prior to such event, the kind and amount of shares of
stock or other securities or property (including cash) receivable upon such
reclassification, reorganization, merger, or consolidation, or upon a
dissolution following any such sale or other transfer, by a Holder of the
number of shares of Common Stock of the Company obtainable upon exercise of
this Warrant immediately prior to such event; and if any reclassification also
results in a change in shares of Common Stock covered by Section 5.1.1 or
5.1.2, then such adjustment shall be made pursuant to Sections 5.1.1, 5.1.2,
5.1.3, and this Section 5.1.4. The provisions of this Section 5.1.4 shall
similarly apply to successive reclassifications, reorganizations, mergers or
consolidations, sales, or other transfers.

                  5.1.5    Changes in Form of Warrant. This form of Warrant
need not be changed because of any change pursuant to this Section, and
Warrants issued after such change may state the same Exercise Price and the
same number of shares of Common Stock and Warrants as are stated in the
Warrants initially issued pursuant to this Agreement. The acceptance by any
Holder of the issuance of new Warrants reflecting a required or permissive
change shall not be deemed to waive any rights to a prior adjustment or the
computation thereof.

         5.2      Elimination of Fractional Interests. The Company shall not be
required to issue certificates representing fractions of shares of Common Stock
upon the exercise of this Warrant, nor shall it be required to issue scrip or
pay cash in lieu of any fractional interests, it being the intent of the
parties that all fractional interests shall be eliminated by rounding any
fraction up to the nearest whole number of shares of Common Stock or other
securities, properties, or rights.

                                      -5-
<PAGE>

6.       Reservation and Listing.

         The Company shall at all times reserve and keep available out of its
authorized shares of Common Stock, solely for the purpose of issuance upon
exercise of this Warrant, such number of shares of Common Stock or other
securities, properties, or rights as shall be issuable upon the exercise
thereof. The Company covenants and agrees that, upon exercise of the Warrants
and payment of the Exercise Price therefor, all shares of Common Stock and
other securities issuable upon such exercise shall be duly and validly issued,
fully paid, and non-assessable and not subject to preemptive rights of any
stockholder. Upon exercise of the Warrant and payment of the Exercise Price
therefor and thereafter, the Company shall use its best efforts to cause all
shares of Common Stock issuable upon exercise of the Warrants to be listed
(subject to official notice of issuance) on all securities exchanges (or, if
applicable on NASDAQ) on which the Common Stock is then listed and/or quoted.

7.       Certain Notice Requirements.

         7.1      Holder's Right to Receive Notice. Nothing herein shall be
construed as conferring upon the Holder the right to vote or consent or to
receive notice as a stockholder for the election of directors or any other
matter, or as having any rights whatsoever as a stockholder of the Company. If,
however, at any time prior to the expiration of the Warrants and their
exercise, any of the events described in Section 7.2 shall occur, then, in one
or more of said events, the Company shall give written notice of such event at
least fifteen days prior to the date fixed as a record date or the date of
closing the transfer books for the determination of the stockholders entitled
to such dividend, distribution, conversion, or exchange of securities or
subscription rights, or entitled to vote on such proposed dissolution,
liquidation, winding up, or sale. Such notice shall specify such record date or
the date of the closing of the transfer books, as the case may be.

         7.2      Events Requiring Notice. The Company shall be required to
give the notice described in this Section 7 upon one or more of the following
events: (i) if the Company shall take a record of the holders of its shares of
Common Stock for the purpose of entitling them to receive a dividend or
distribution, or (ii) the Company shall offer to all the holders of its Common
Stock any additional shares of capital stock of the Company or securities
convertible into or exchangeable for shares of capital stock of the Company, or
any option, right, or warrant to subscribe therefor, or (iii) a merger or
reorganization in which the Company is not the surviving party, or (iv) a
dissolution, liquidation, or winding up of the Company (other than in
connection with a consolidation or merger) or a sale of all or substantially
all of its property, assets, and business shall be proposed.

         7.3      Notice of Change in Exercise Price. The Company shall,
promptly after an event requiring a change in the Exercise Price pursuant to
Section 5 hereof, send notice to the Holder of such event and change ("Price
Notice"). The Price Notice shall describe the event causing the change and the
method of calculating same and shall be certified as being true and accurate by
the Company's President and Chief Financial Officer.

         7.4      Transmittal of Notices. All notices, requests, consents, and
other communications under this Warrant shall be in writing and shall be deemed
to have been duly made on the date of delivery if delivered personally or sent
by overnight courier, with acknowledgement of receipt by the party to which
notice is given, or the fifth day after mailing if mailed to the party to whom
notice is to be given, by registered or certified mail, return receipt
requested, postage prepaid, and properly addressed as follows: (i) if to the

                                      -6-
<PAGE>

registered Holder of this Warrant, to the address of such Holder as shown on
the books of the Company, or (ii) if to the Company, to its principal office.

8.       Miscellaneous.

         8.1      Headings. The headings contained herein are for the sole
purpose of convenience of reference, and shall not in any way limit or affect
the meaning or interpretation of any of the terms or provisions of this
Warrant.

         8.2      Entire Agreement. This Warrant (together with the other
agreements and documents being delivered pursuant to or in connection with this
Warrant) constitutes the entire agreement of the parties hereto with respect to
the subject matter hereof, and supersedes all prior agreements and
understandings of the parties, oral and written, with respect to the subject
matter hereof.

         8.3      Binding Effect. This Warrant shall inure solely to the
benefit of and shall be binding upon, the Holder and the Company and their
respective successors, legal representatives, and assigns, and no other person
shall have or be construed to have any legal or equitable right, remedy, or
claim under or in respect of or by virtue of this Warrant or any provisions
herein contained.

         8.4      Governing Law; Submission to Jurisdiction. This Warrant shall
be governed by and construed and enforced in accordance with the laws of the
State of Georgia, without giving effect to conflict of laws. The Company hereby
agrees that any action, proceeding, or claim against it arising out of, or
relating in any way to this Warrant shall be brought and enforced in the courts
of the State of Georgia or of the United States of America in a district court
located in the State of Georgia, and irrevocably submits to such jurisdiction,
which jurisdiction shall be exclusive. The Company hereby waives any objection
to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process or summons to be served upon the Company may be served by
transmitting a copy thereof by registered or certified mail, return receipt
requested, postage prepaid, addressed to it at the address set forth in Section
7 hereof. Such mailing shall be deemed personal service and shall be legal and
binding upon the Company in any action, proceeding, or claim.

         8.5      Waiver, etc. The failure of the Company or the Holder to at
any time enforce any of the provisions of this Warrant shall not be deemed or
construed to be a waiver of any such provision, nor to in any way affect the
validity of this Warrant or any provision hereof or the right of the Company or
any Holder to thereafter enforce each and every provision of this Warrant. No
waiver of any breach, non-compliance, or non-fulfillment of any of the
provisions of this Warrant shall be effective unless set forth in a written
instrument executed by the party or parties against whom or which enforcement
of such waiver is sought; and no waiver of any such breach, non-compliance, or
non-fulfillment shall be construed or deemed to be a waiver of any other or
subsequent breach, non-compliance, or non-fulfillment.

         8.6      Exchange Agreement. As a condition of the Holder's receipt
and acceptance of this Warrant, the Holder agrees that, at any time prior to
the complete exercise of this Warrant by the Holder, if the Company and Epoch
Financial Group, Inc. enter into an agreement ("Exchange Agreement") pursuant
to which they agree that all outstanding Warrants will be exchanged for
securities or cash or a combination of both, then the Holder shall agree to
such exchange and become a party to the Exchange Agreement.

                                      -7-
<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed
by its duly authorized officer as of the 26 day of September, 2002.

                                HORIZON MEDICAL PRODUCTS, INC.

                                By: /s/ William E. Peterson, Jr.
                                   -----------------------------------
                                   William E. Peterson, Jr., President

                                      -8-<PAGE>

                                                                   EXHIBIT 10.1

                                                     August  21, 2002

Mr. Gustavo Benejam
8185 Twin Lake Drive
Boca Raton, FL 33496

                   SEPARATION AGREEMENT AND RELEASE OF CLAIMS

Dear Mr. Benejam:

         This letter will serve as confirmation that your employment with
America Online Latin America, Inc. ("AOLA", together with any successors,
subsidiaries, merged entities, parent entities and their respective affiliates,
collectively the "Company") will end as set forth in this letter. This
Separation Agreement and Release of Claims ("Agreement"), upon your signature,
will constitute the complete agreement between you and the Company regarding the
terms of your separation of employment.

1.       Subject to paragraph 3A, your employment with the Company will cease at
         the close of business on September 30, 2003 (the "Separation Date") on
         the terms and conditions set forth in this Agreement. Effective at the
         close of business on September 30, 2002 (the "Trigger Date"), you will
         cease to perform your regular duties for the Company, you shall no
         longer have authority to bind the Company and you shall not hold
         yourself out to third parties as having such authority; provided, that
         you shall perform duties for the Company after the Trigger Date from
         time to time if and as reasonably requested by the Company until the
         close of business on the Separation Date, subject to your availability.

2.       You will continue to be paid your salary (at the current annual rate)
         and be provided with the Company's standard benefit package (including
         health benefits, life insurance, continued participation in stock
         option plans with respect to stock options granted to you prior to the
         date hereof and participation in the Company's 401(k) plan) through the
         Separation Date. To the extent not covered by the Company's current
         health plan, the Company will reimburse you for the reasonable
         out-of-pocket cost of your regular executive physical examination for
         2002 and 2003. The last salary payment, together with payment for
         accrued and unused vacation (you will continue to accrue, through the
         Separation Date, vacation days at the rate

                                        1
<PAGE>

         of four weeks per year, subject to proportional reduction pursuant to
         paragraph 3A) through the Separation Date, will be made on or before
         the next regularly scheduled pay date following the Separation Date.
         The Company acknowledges that as of the date hereof, you have 19
         accrued and unpaid vacation days. In addition, you will be paid, on
         January 3, 2003 with respect to fiscal year 2002, 100% of the annual
         bonus for which you were eligible for fiscal year 2002, which is an
         amount equal to $167,500. You will not be eligible for any bonus for
         any period following fiscal year 2002. You will not be entitled to
         receive any additional stock options following the date hereof.
         Applicable payroll deductions and appropriate tax withholdings will be
         made from all salary and other payments made pursuant to this
         paragraph.

3.       Your health benefits will continue through the Separation Date. With
         respect to the Consolidated Omnibus Budget Reconciliation Act
         ("COBRA"), your COBRA period will begin on the day following the
         Separation Date. You will receive separate information regarding your
         option to continue, at your expense under COBRA, health benefits after
         the Separation Date. All other benefits will terminate on the
         Separation Date.

3A. At any time during the term of this Agreement, you will have the option to
notify the Company (the "Acceleration Notice") that you have elected for the
Separation Date to occur on a date (the "Accelerated Date") specified in the
Acceleration Notice, which date shall be not less than 15 business days
following the date of the Acceleration Notice. If you give the Acceleration
Notice, you will be entitled to receive a lump sum payment equivalent to the
aggregate amount of salary that would have been payable to you from the date of
the Acceleration Notice through the original Separation Date (together with
payment for accrued and unpaid vacation days as described in paragraph 2), and
the Accelerated Date shall immediately become the Separation Date for all other
purposes of this Agreement. The lump sum payment will be made on the Accelerated
Date. Except as provided in this paragraph 3, the giving of the Acceleration
Notice will not modify or effect the validity of this Agreement.

4.       Prior to your departure from work on the Trigger Date, you must return
         to the Company all the Company property in your possession, including,
         but not limited to, keys, pagers, and the original and all copies of
         any written, recorded, or computer-readable information about Company
         practices, procedures, trade secrets, customer lists, or product
         marketing associated with the Company's online services business;
         provided, that you may retain following the Separation Date your
         cellular phone and your laptop computer (after all Company confidential
         information has been removed from the hard drive). As provided in
         AOLA's Confidential Information, Non-Competition and Proprietary Rights
         Agreement which you signed dated June 18, 2000 (the "NDA"), you have
         agreed not to disclose to others information about the Company's
         practices, procedures, trade secrets, customer lists, or product
         marketing, except as required by law, and that agreement remains in
         full force and effect, and shall remain in full force and effect
         following your separation from the Company. In addition, (i) upon your
         request, and subject to the applicable policies of Sprint PCS, the
         Company will transfer into your name the cellular telephone number and
         account with Sprint

                                        2
<PAGE>

         PCS currently attributed to you, provided that you will then be
         financially responsible for such account and (ii) you will be entitled
         to keep your AOL screennames and AOL account (subject to the terms of
         service and other terms and conditions that may be imposed by AOL,
         Inc.), provided that you will then be financially responsible for such
         account.

5.       In addition, the services of Drake Beam Morin, a professional
         outplacement and counseling firm, will be provided to you, at the
         Company's expense, through March 31, 2003, to assist you in securing
         other employment.

6.       The agreement of the Company to extend your employment past the Trigger
         Date and to agree to pay you your full bonus with respect to fiscal
         year 2002 as set forth above are being offered solely in consideration
         for your release of claims, as set forth in Paragraph 7, your
         compliance with the terms of this Agreement and your continued
         compliance with the NDA as set forth above. Such agreements are not,
         and should not be construed as, an admission of any kind whatsoever by
         the Company, and the Company denies it has engaged in any wrongdoing
         against you.

7.       In consideration of the Company's agreement as stated above, you agree
         to discharge and release unconditionally the Company, ADP TotalSource
         (as co-employer), their successors and their respective predecessors,
         subsidiaries, affiliates, related entities, merged entities and their
         parent entities, and their respective officers, directors,
         stockholders, employees, benefit plan administrators and trustees,
         agents, attorneys, insurers, representatives, affiliates, successors
         and assigns (the "Releasees") from any and all claims, actions, causes
         of action, demands, obligations or damages of whatever nature, whether
         known or unknown to you, which you ever had or now have upon or by
         reason of any matter, cause or thing, up to and including the day on
         which you sign this Agreement, arising from your employment with the
         Company and separation of your employment with the Company or
         otherwise, including any claim arising out of or related to any stock
         options held by you or granted to you by the Company which are
         scheduled to vest subsequent to your Separation Date (all of the
         foregoing, collectively "Claims"). The Claims you are waiving include,
         but are not limited to, any and all claims arising out of or related to
         or under: the employment letter between you and the Company dated
         February 28, 2000, any stock options held by you or granted to you by
         the Company which are scheduled to vest subsequent to your Separation
         Date; the Employee Retirement Income Security Act; Title VII of the
         Civil Rights Act of 1964, as amended; the Americans with Disabilities
         Act; the Age Discrimination in Employment Act; the Fair Labor Standards
         Act; the Worker Adjustment and Retraining Notification Act (WARN), or
         similar statutes; the Fair Labor Standards Act; the Family Leave and
         Medical Act; the National Labor Relations Act; the Employee
         Retirement Income Security Act; 42 U.S.C. 1981; the Older Workers
         Benefits Protection Act; Chapter 760, Florida Statutes; Chapter 448,
         Florida Statutes; analogous federal, state and local laws, regulations,
         statutes or ordinances; any principle of common law; all claims for any
         type of relief from the Releasees, and any other federal, state and
         local claims, whether statutory or common law, and whether tort or
         contract. This release of claims does not affect any pending claim for

                                        3
<PAGE>

         workers' compensation benefits, your vested rights, if any, in the
         Company's 401(k) plan, or your rights to exercise any and all Company
         stock options held by you that are exercisable as of your Separation
         Date during the applicable period of exercise and in accordance with
         all other terms of those options and the stock option plans, agreements
         and notices under which such options were granted. In addition, this
         Agreement is not intended to impair any rights, if any, to
         indemnification that you may have pursuant to the Company's
         organizational documents or insurance policies related to your duties
         as Officer or Employee of the Company.

8.       You agree to assist the Company, upon its reasonable request, in
         connection with any litigation, investigation or other matter arising
         out of or related to your service as an employee, officer, or director
         of the Company. The Company will reimburse you for the reasonable
         out-of-pocket costs incurred by you in rendering such assistance to the
         Company.

9.       You represent and agree that you have not filed any complaint or charge
         or lawsuit of any kind whatsoever against the Company with any other
         governmental agency or any court and you further represent and agree
         that you will not file or institute or participate in any litigation,
         award or judgment with any State or Federal court any time hereafter
         or, unless required by law or pursuant to Paragraph 8 above, testify or
         provide documents or information for or to any other person or entity
         with regard to any matter related to or arising out of your employment
         with the Company or the termination thereof, this Agreement or any
         matters released herein; provided, that this shall not limit you from
         filing a lawsuit for the purpose of enforcing your rights under this
         Agreement.

10.      You understand and agree that the terms of this agreement are
         confidential, and you agree not to disclose to others the terms of this
         Agreement, except as required by law or with the written consent of the
         Company, provided, however, that this paragraph does not preclude
         disclosure to your immediate family or for purposes of securing
         professional financial, tax or legal services, provided further that
         prior to making any such disclosure you will inform any such persons
         that this confidentiality clause is in effect and that they are bound
         by it.

11.      You agree not to make any untruthful remarks or statements about the
         Releasees and their respective officers, directors, employees or
         agents. You agree that this Agreement will be filed by the Company with
         the United States Securities and Exchange Commission.

12.      You agree that in the event you breach any of your obligations under
         paragraph 1, 4, 8, 9, 10 or 11 of this Agreement, the Company will be
         entitled to seek recovery or setoff of the full amount of the salary
         and bonus paid or to be paid to you following September 30, 2002.

13.      If the payments and benefits provided under this Agreement to you,
         either alone or with other payments and benefits, would constitute
         "excessive parachute payments" as defined in Section 280G of the
         Internal Revenue Code of 1986, as amended ("Code"), then the payments
         and other benefits under this Agreement shall be reduced to the extent
         necessary so

                                        4
<PAGE>

         that no portion thereof shall be subject to the excise tax imposed by
         Section 4999 of the Code. Either you or the Company may request a
         determination as to whether the payments or benefits would constitute
         an excess parachute payment and, if requested, such determination shall
         be made by independent tax counsel selected by the Company and approved
         by you. At your election and to the extent not otherwise paid, you may
         determine the amount of cash and/or elements of non-cash fringe
         benefits to reduce so that such payments and benefits will not
         constitute excess parachute payments.

14.      This Agreement shall be governed by and construed in accordance with
         the laws of the State of Florida, with regard to any otherwise
         applicable principles of conflicts of law.

15.      If any portion of this Agreement should ever be determined to be
         unenforceable, it is agreed that this will not affect the
         enforceability of any other clause of the remainder of this Agreement.

16.      You understand that you have been given a period of 45 days to review
         and consider this Agreement and to consult with an attorney and other
         advisors of your choice before signing it. You further understand that
         you may use as much of this 45-day period as you wish prior to signing.
         You further acknowledge that you have received certain supplemental
         information, which constitutes the disclosure required to be provided
         under the Older Workers Benefit Protection Act.

17.      You may revoke this Agreement within seven (7) days of signing it.
         Revocation can be made by delivering written notice of revocation to
         America Online Latin America, Inc., 6600 N. Andrews Ave., Suite 400,
         Ft. Lauderdale, FL 33309, Attn: President. For this revocation to be
         effective, written notice must be received by the President of the
         Company no later than the close of business on the seventh day after
         you sign this Agreement. If you revoke this Agreement, it shall not be
         effective or enforceable and Employee will not receive the benefits
         described in this Agreement.

                                           Sincerely,

                                           /s/ Charles M. Herington
                                           --------------------------
                                           Charles M. Herington
                                           President and Chief Executive Officer
                                           America Online Latin America, Inc.

                                       5
<PAGE>

By signing this letter, I acknowledge that I have had the opportunity to review
this agreement carefully with legal or other personal advisors of my own choice;
I understand that by signing this agreement I am releasing the Company from all
claims against it; that I have read this agreement and understand its terms;
that I have been given a reasonable period of time to consider its terms and
effect and to ask any questions I may have; and that I voluntarily agree to
them.

/s/ Gustavo Benejam                                         Dated: 8/23/02
--------------------------------                            -------------------
Gustavo Benejam

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00045-of-00352.parquet"}]]